Stay updated on Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Sign up to get notified when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.6.5 to v3.6.6. This reflects a software release for the site.
    Difference
    0.1%
    Check dated 2026-08-29T22:12:28.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now shown in the page footer, replacing Revision: v3.6.4. This is a minor platform update and does not affect the study history content.
    Difference
    0.0%
    Check dated 2026-08-08T17:06:38.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The record history shows a new revision label, v3.6.4, replacing the previous v3.6.3, reflecting an updated version of the page history.
    Difference
    0.0%
    Check dated 2026-07-25T10:53:29.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The revision label in the page footer updates from v3.6.2 to v3.6.3. This reflects a minor site update without altering study data or page functionality.
    Difference
    0.0%
    Check dated 2026-07-03T23:58:24.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.2, replacing the previous v3.6.0, indicating a small site update; the study history information remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-27T01:20:58.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Version history shows a new revision v3.6.0 replacing v3.5.5. A note has been added stating the study is no longer looking for participants.
    Difference
    0.2%
    Check dated 2026-06-12T14:50:30.000Z thumbnail image

Stay in the know with updates to Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.